The DOI matches its Crossref record; 385 of the 385 references it cites were found in a registry or an index.
Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives
Open accessAbstract
Ocular diseases seriously affect patients' vision and life quality, with a global morbidity of over 43 million blindness. However, efficient drug delivery to treat ocular diseases, particularly intraocular disorders, remains a huge challenge due to multiple ocular barriers that significantly affect the ultimate therapeutic efficacy of drugs. Recent advances in nanocarrier technology offer a promising opportunity to overcome these barriers by providing enhanced penetration, increased retention, improved solubility, reduced toxicity, prolonged release, and targeted delivery of the loaded drug to the eyes. This review primarily provides an overview of the progress and contemporary applications of nanocarriers, mainly polymer- and lipid-based nanocarriers, in treating various eye diseases, highlighting their value in achieving efficient ocular drug delivery. Additionally, the review covers the ocular barriers and administration routes, as well as the prospective future developments and challenges in the field of nanocarriers for treating ocular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
Tham, Y.-C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C.-Y. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.05.013 · Cited by 7,159
TFOS DEWS II Definition and Classification Report
Craig, J. P., Nichols, K. K., Akpek, E. K., Caffery, B., Dua, H. S., Joo, C.-K., Liu, Z., Nelson, J. D., Nichols, J. J., Tsubota, K., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.008 · Cited by 3,383
Cheung, N., Mitchell, P., & Wong, T. Y. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62124-3 · Cited by 3,288
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
Liu, Y., Bhattarai, P., Dai, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00618k · Cited by 2,904
VEGF in signaling and disease: beyond discovery and development
Apte, R. S., Chen, D. S., & Ferrara, N. (2019) · Cell · doi:10.1016/j.cell.2019.01.021 · Cited by 2,721
TFOS DEWS II Epidemiology Report
Stapleton, F., Alves, M., Bunya, V. Y., Jalbert, I., Lekhanont, K., Malet, F., Na, K.-S., Schaumberg, D., Uchino, M., Vehof, J., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.003 · Cited by 2,618
Functional Nanomaterials for Phototherapies of Cancer
Cheng, L., Wang, C., Feng, L., Yang, K., & Liu, Z. (2014) · Chemical Reviews · doi:10.1021/cr400532z · Cited by 2,425
Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
TFOS DEWS II pathophysiology report
Bron, A. J., de Paiva, C. S., Chauhan, S. K., Bonini, S., Gabison, E. E., Jain, S., Knop, E., Markoulli, M., Ogawa, Y., Perez, V., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.011 · Cited by 1,815
The Lancet Global Health Commission on Global Eye Health: vision beyond 2020
Burton, M. J., Ramke, J., Marques, A. P., Bourne, R. R. A., Congdon, N., Jones, I., Ah Tong, B. A. M., Arunga, S., Bachani, D., Bascaran, C., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30488-5 · Cited by 1,624
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Karimi, M., Ghasemi, A., Sahandi Zangabad, P., Rahighi, R., Moosavi Basri, S. M., Mirshekari, H., Amiri, M., Shafaei Pishabad, Z., Aslani, A., Bozorgomid, M., et al. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00798d · Cited by 1,519
Age-related macular degeneration
Mitchell, P., Liew, G., Gopinath, B., & Wong, T. Y. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31550-2 · Cited by 1,511
Cone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30425-3 · Cited by 1,431
TFOS DEWS II Management and Therapy Report
Jones, L., Downie, L. E., Korb, D., Benitez-del-Castillo, J. M., Dana, R., Deng, S. X., Dong, P. N., Geerling, G., Hida, R. Y., Liu, Y., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.006 · Cited by 1,422
Self-citationAge-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
Wong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S., & Simó, R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.12 · Cited by 1,094
Preservatives in eyedrops: The good, the bad and the ugly
Baudouin, C., Labbé, A., Liang, H., Pauly, A., & Brignole-Baudouin, F. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.03.001 · Cited by 1,084
FDA-approved small-molecule kinase inhibitors
Wu, P., Nielsen, T. E., & Clausen, M. H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.005 · Cited by 1,013
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
Large, D. E., Abdelmessih, R. G., Fink, E. A., & Auguste, D. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113851 · Cited by 877
Kalia, Y. N., Naik, A., Garrison, J., & Guy, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.026 · Cited by 858
Impact of Dry Eye Syndrome on Vision-Related Quality of Life
Miljanović, B., Dana, R., Sullivan, D. A., & Schaumberg, D. A. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.11.060 · Cited by 838
Leber congenital amaurosis: Genes, proteins and disease mechanisms
den Hollander, A. I., Roepman, R., Koenekoop, R. K., & Cremers, F. P. M. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.003 · Cited by 811
Amphotericin B formulations: a comparative review of efficacy and toxicity
Hamill, R. J. (2013) · Drugs · doi:10.1007/s40265-013-0069-4 · Cited by 807
Glaucoma in Adults—Screening, Diagnosis, and Management: A Review
Stein, J. D., Khawaja, A. P., & Weizer, J. S. (2021) · JAMA · doi:10.1001/jama.2020.21899 · Cited by 728
Corneal avascularity is due to soluble VEGF receptor-1
Ambati, B. K., Nozaki, M., Singh, N., Takeda, A., Jani, P. D., Suthar, T., Albuquerque, R. J. C., Richter, E., Sakurai, E., Newcomb, M. T., et al. (2006) · Nature · doi:10.1038/nature05249 · Cited by 684
siRNA vs. shRNA: Similarities and differences
Rao, D. D., Vorhies, J. S., Senzer, N., & Nemunaitis, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.004 · Cited by 660
Asbell, P. A., Dualan, I., Mindel, J. S., Brocks, D., Ahmad, M., & Epstein, S. P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17911-2 · Cited by 659
Summers Rada, J. A., Shelton, S., & Norton, T. T. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.08.009 · Cited by 566
The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Fleckenstein, M., Mitchell, P., Freund, K. B., Sadda, S., Holz, F. G., Brittain, C., Henry, E. C., & Ferrara, D. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2017.08.038 · Cited by 561
Molecular pathogenesis of retinal and choroidal vascular diseases
Campochiaro, P. A. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.06.002 · Cited by 545
Webvision: The Organization of the Retina and Visual System
Kolb, H., Fernández, E., & Nelson, R. (1995) · Cited by 544
Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications
Kannan, R. M., Nance, E., Kannan, S., & Tomalia, D. A. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12280 · Cited by 542
Cunha-Vaz, J., Bernardes, R., & Lobo, C. (2011) · European Journal of Ophthalmology · doi:10.5301/ejo.2010.6049 · Cited by 539
The Pathophysiology of Dry Eye Disease
Pflugfelder, S. C., & de Paiva, C. S. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.07.010 · Cited by 533
Degree, duration, and causes of visual loss in uveitis
Durrani, O. M. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.037226 · Cited by 529
Bacterial and Fungal Endophthalmitis
Durand, M. L. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00113-16 · Cited by 520
Peptide–drug conjugates as effective prodrug strategies for targeted delivery
Wang, Y., Cheetham, A. G., Angacian, G., Su, H., Xie, L., & Cui, H. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.015 · Cited by 514
Cubosomes: The Next Generation of Smart Lipid Nanoparticles?
Barriga, H. M. G., Holme, M. N., & Stevens, M. M. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804067 · Cited by 505
Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.012 · Cited by 481
Uveal melanoma: From diagnosis to treatment and the science in between
Chattopadhyay, C., Kim, D. W., Gombos, D. S., Oba, J., Qin, Y., Williams, M. D., Esmaeli, B., Grimm, E. A., Wargo, J. A., Woodman, S. E., et al. (2016) · Cancer · doi:10.1002/cncr.29727 · Cited by 443
Dias, M. F., Joo, K., Kemp, J. A., Fialho, S. L., da Silva Cunha, A., Woo, S. J., & Kwon, Y. J. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.004 · Cited by 413
Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases
Hanany, M., Rivolta, C., & Sharon, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913179117 · Cited by 408
Advances and limitations of drug delivery systems formulated as eye drops
Jumelle, C., Gholizadeh, S., Annabi, N., & Dana, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.057 · Cited by 408
Cuenca, N., Fernández-Sánchez, L., Campello, L., Maneu, V., De la Villa, P., Lax, P., & Pinilla, I. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.07.001 · Cited by 401
Espinosa-Heidmann, D. G., Suner, I. J., Hernandez, E. P., Monroy, D., Csaky, K. G., & Cousins, S. W. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0038 · Cited by 401
Topical and systemic drug delivery to the posterior segments
HUGHES, P., OLEJNIK, O., CHANGLIN, J., & WILSON, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.004 · Cited by 400
Liu, C., Wan, T., Wang, H., Zhang, S., Ping, Y., & Cheng, Y. (2019) · Science Advances · doi:10.1126/sciadv.aaw8922 · Cited by 396
Liposomes as biocompatible and smart delivery systems – the current state
Dymek, M., & Sikora, E. (2022) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2022.102757 · Cited by 392
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Ragelle, H., Danhier, F., Préat, V., Langer, R., & Anderson, D. G. (2017) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1244187 · Cited by 390
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Ding, D., & Zhu, Q. (2018) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.12.036 · Cited by 386
Nanotechnology-based strategies for treatment of ocular disease
Weng, Y., Liu, J., Jin, S., Guo, W., Liang, X., & Hu, Z. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.001 · Cited by 375
Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences
Pastor, J. C., Rojas, J., Pastor-Idoate, S., Di Lauro, S., Gonzalez-Buendia, L., & Delgado-Tirado, S. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.07.005 · Cited by 344
Nanoparticles for drug delivery to the anterior segment of the eye
Janagam, D. R., Wu, L., & Lowe, T. L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.001 · Cited by 341
Biousse, V., & Newman, N. J. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1413352 · Cited by 341
Drug delivery to the posterior segment of the eye
Thrimawithana, T. R., Young, S., Bunt, C. R., Green, C., & Alany, R. G. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.12.004 · Cited by 335
Glaucoma 2.0: Neuroprotection, Neuroregeneration, Neuroenhancement
Chang, E. E., & Goldberg, J. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.11.003 · Cited by 327
Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo
Xu, Q., Boylan, N. J., Suk, J. S., Wang, Y.-Y., Nance, E. A., Yang, J.-C., McDonnell, P. J., Cone, R. A., Duh, E. J., & Hanes, J. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.018 · Cited by 326
Costa, C. P., Moreira, J. N., Sousa Lobo, J. M., & Silva, A. C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.012 · Cited by 303
De, R., Mahata, M. K., & Kim, K. (2022) · Advanced Science · doi:10.1002/advs.202105373 · Cited by 297
Lipid-based nanoparticle technologies for liver targeting
Böttger, R., Pauli, G., Chao, P.-H., AL Fayez, N., Hohenwarter, L., & Li, S.-D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.017 · Cited by 264
Self-citationNanotechnology for angiogenesis: opportunities and challenges
Kargozar, S., Baino, F., Hamzehlou, S., Hamblin, M. R., & Mozafari, M. (2020) · Chemical Society Reviews · doi:10.1039/c8cs01021h · Cited by 262
Nanomedicines for back of the eye drug delivery, gene delivery, and imaging
Kompella, U. B., Amrite, A. C., Pacha Ravi, R., & Durazo, S. A. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.04.001 · Cited by 258
Periocular routes for retinal drug delivery
Raghava, S., Hammond, M., & Kompella, U. B. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.99 · Cited by 257
A Hydrogel-Based Hybrid Theranostic Contact Lens for Fungal Keratitis
Huang, J.-F., Zhong, J., Chen, G.-P., Lin, Z.-T., Deng, Y., Liu, Y.-L., Cao, P.-Y., Wang, B., Wei, Y., Wu, T., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b00601 · Cited by 257
Leber congenital amaurosis due to RPE65 mutations and its treatment with gene therapy
Cideciyan, A. V. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.002 · Cited by 256
The management of retinoblastoma
Fabian, I. D., Onadim, Z., Karaa, E., Duncan, C., Chowdhury, T., Scheimberg, I., Ohnuma, S.-I., Reddy, M. A., & Sagoo, M. S. (2018) · Oncogene · doi:10.1038/s41388-017-0050-x · Cited by 250
Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles
Gong, C., Deng, S., Wu, Q., Xiang, M., Wei, X., Li, L., Gao, X., Wang, B., Sun, L., Chen, Y., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.068 · Cited by 244
Corneal Biomechanics and Biomaterials
Ruberti, J. W., Sinha Roy, A., & Roberts, C. J. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-070909-105243 · Cited by 241
Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
Tsai, C.-H., Wang, P.-Y., Lin, I.-C., Huang, H., Liu, G.-S., & Tseng, C.-L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092830 · Cited by 240
Subrizi, A., del Amo, E. M., Korzhikov-Vlakh, V., Tennikova, T., Ruponen, M., & Urtti, A. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.02.001 · Cited by 239
Neuroprotective strategies for retinal disease
Pardue, M. T., & Allen, R. S. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.02.002 · Cited by 237
Ocular delivery of macromolecules
Kim, Y. C., Chiang, B., Wu, X., & Prausnitz, M. R. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.043 · Cited by 232
Evaluation and Care of Patients with Diabetic Retinopathy
Jampol, L. M., Glassman, A. R., & Sun, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909637 · Cited by 230
Eye: anatomy, physiology and barriers to drug delivery
Cholkar, K., Dasari, S. R., Pal, D., & Mitra, A. K. (2013) · Elsevier eBooks · doi:10.1533/9781908818317.1 · Cited by 228
Radu, R. A., Mata, N. L., Nusinowitz, S., Liu, X., Sieving, P. A., & Travis, G. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737855100 · Cited by 227
Overcoming ocular drug delivery barriers through the use of physical forces
Huang, D., Chen, Y.-S., & Rupenthal, I. D. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.008 · Cited by 227
A review on recent drug delivery systems for posterior segment of eye
Nayak, K., & Misra, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.138 · Cited by 225
D-mannose suppresses macrophage IL-1β production
Torretta, S., Scagliola, A., Ricci, L., Mainini, F., Di Marco, S., Cuccovillo, I., Kajaste-Rudnitski, A., Sumpton, D., Ryan, K. M., & Cardaci, S. (2020) · Nature Communications · doi:10.1038/s41467-020-20164-6 · Cited by 224
A lipid based depot (DepoFoam® technology) for sustained release drug delivery
Mantripragada, S. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(02)00004-8 · Cited by 221
Depression and anxiety in dry eye disease: a systematic review and meta-analysis
Wan, K. H., Chen, L. J., & Young, A. L. (2016) · Eye · doi:10.1038/eye.2016.186 · Cited by 219
Qiao, Y., He, J., Chen, W., Yu, Y., Li, W., Du, Z., Xie, T., Ye, Y., Hua, S. Y., Zhong, D., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b08930 · Cited by 216
Self-citationScott, I. U., VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Awh, C. C., Kunimoto, D. Y., Marcus, D. M., Wroblewski, J. J., King, J., et al. (2017) · JAMA · doi:10.1001/jama.2017.4568 · Cited by 215
Koo, H., Moon, H., Han, H., Na, J. H., Huh, M. S., Park, J. H., Woo, S. J., Park, K. H., Chan Kwon, I., Kim, K., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.030 · Cited by 214
Self-citationAddressing MRSA infection and antibacterial resistance with peptoid polymers
Xie, J., Zhou, M., Qian, Y., Cong, Z., Chen, S., Zhang, W., Jiang, W., Dai, C., Shao, N., Ji, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26221-y · Cited by 213
Corneal stromal repair and regeneration
Mohan, R. R., Kempuraj, D., D'Souza, S., & Ghosh, A. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101090 · Cited by 212
Overcoming negatively charged tissue barriers: Drug delivery using cationic peptides and proteins
Vedadghavami, A., Zhang, C., & Bajpayee, A. G. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100898 · Cited by 211
Maya-Vetencourt, J. F., Manfredi, G., Mete, M., Colombo, E., Bramini, M., Di Marco, S., Shmal, D., Mantero, G., Dipalo, M., Rocchi, A., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0696-3 · Cited by 211
Photoreceptor cells and RPE contribute to the development of diabetic retinopathy
Tonade, D., & Kern, T. S. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100919 · Cited by 209
Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy
Zhang, S. X., & Ma, J.-X. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2006.09.002 · Cited by 208
Singh, S. R., Grossniklaus, H. E., Kang, S. J., Edelhauser, H. F., Ambati, B. K., & Kompella, U. B. (2009) · Gene Therapy · doi:10.1038/gt.2008.185 · Cited by 204
Posterior capsule opacification: What's in the bag?
Wormstone, I. M., Wormstone, Y. M., Smith, A. J. O., & Eldred, J. A. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100905 · Cited by 203
Current and emerging therapies for corneal neovascularization
Roshandel, D., Eslani, M., Baradaran-Rafii, A., Cheung, A. Y., Kurji, K., Jabbehdari, S., Maiz, A., Jalali, S., Djalilian, A. R., & Holland, E. J. (2018) · The Ocular Surface · doi:10.1016/j.jtos.2018.06.004 · Cited by 200
Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
Kim, H. M., & Woo, S. J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010108 · Cited by 198
Mucins as multifunctional building blocks of biomaterials
Petrou, G., & Crouzier, T. (2018) · Biomaterials Science · doi:10.1039/c8bm00471d · Cited by 198
Ideta, R., Tasaka, F., Jang, W.-D., Nishiyama, N., Zhang, G.-D., Harada, A., Yanagi, Y., Tamaki, Y., Aida, T., & Kataoka, K. (2005) · Nano Letters · doi:10.1021/nl051679d · Cited by 196
Smart Nanotherapeutic Targeting of Tumor Vasculature
Li, Z., Di, C., Li, S., Yang, X., & Nie, G. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00283 · Cited by 196
Self-citationOphthalmic gels: Past, present and future
Al-Kinani, A. A., Zidan, G., Elsaid, N., Seyfoddin, A., Alani, A. W. G., & Alany, R. G. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.017 · Cited by 194
Drug Delivery to the Eye: What Benefits do Nanocarriers offer?
Joseph, R. R., & Venkatraman, S. S. (2017) · Nanomedicine · doi:10.2217/nnm-2016-0379 · Cited by 192
Khames, A., Khaleel, M. A., El-Badawy, M. F., & El-Nezhawy, A. O. H. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s190502 · Cited by 191
Early and late stage gene therapy interventions for inherited retinal degenerations
Botto, C., Rucli, M., Tekinsoy, M. D., Pulman, J., Sahel, J.-A., & Dalkara, D. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100975 · Cited by 190
Cataract: Advances in surgery and whether surgery remains the only treatment in future
Chen, X., Xu, J., Chen, X., & Yao, K. (2021) · Advances in Ophthalmology Practice and Research · doi:10.1016/j.aopr.2021.100008 · Cited by 189
Self-citationNanomaterials for Ocular Drug Delivery
Liu, S., Jones, L., & Gu, F. X. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201100419 · Cited by 185
Mofidfar, M., Abdi, B., Ahadian, S., Mostafavi, E., Desai, T. A., Abbasi, F., Sun, Y., Manche, E. E., Ta, C. N., & Flowers, C. W. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120924 · Cited by 184
Surface Modification of Lipid-Based Nanoparticles
Xu, Y., Fourniols, T., Labrak, Y., Préat, V., Beloqui, A., & des Rieux, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c02347 · Cited by 184
Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases
Bock, F., Maruyama, K., Regenfuss, B., Hos, D., Steven, P., Heindl, L. M., & Cursiefen, C. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.01.001 · Cited by 183
Nanotherapies for the treatment of ocular diseases
Reimondez-Troitiño, S., Csaba, N., Alonso, M. J., & de la Fuente, M. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.019 · Cited by 182
Novel nanomedicines to overcome cancer multidrug resistance
Su, Z., Dong, S., Zhao, S.-C., Liu, K., Tan, Y., Jiang, X., Assaraf, Y. G., Qin, B., Chen, Z.-S., & Zou, C. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100777 · Cited by 182
Age-related macular degeneration: A two-level model hypothesis
Rozing, M. P., Durhuus, J. A., Krogh Nielsen, M., Subhi, Y., Kirkwood, T. B., Westendorp, R. G., & Sørensen, T. L. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.100825 · Cited by 180
Ocular Drug Delivery Nanowafer with Enhanced Therapeutic Efficacy
Yuan, X., Marcano, D. C., Shin, C. S., Hua, X., Isenhart, L. C., Pflugfelder, S. C., & Acharya, G. (2015) · ACS Nano · doi:10.1021/nn506599f · Cited by 177
Qi, J., Dai, Zhou, Lu, Y., Wu, W., & Liu (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s44487 · Cited by 176
Nanotherapy for posterior eye diseases
Kaur, I. P., & Kakkar, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.031 · Cited by 175
Polymer-based carriers for ophthalmic drug delivery
Imperiale, J. C., Acosta, G. B., & Sosnik, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.031 · Cited by 175
Anti-oxidative and anti-inflammatory micelles: break the dry eye vicious cycle
Li, S., Lu, Z., Huang, Y., Wang, Y., Jin, Q., Shentu, X., Ye, J., Ji, J., Yao, K., & Han, H. (2022) · Advanced Science · doi:10.1002/advs.202200435 · Cited by 174
Self-citationBarrier analysis of periocular drug delivery to the posterior segment
Ranta, V.-P., Mannermaa, E., Lummepuro, K., Subrizi, A., Laukkanen, A., Antopolsky, M., Murtomäki, L., Hornof, M., & Urtti, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.028 · Cited by 173
Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation
Soiberman, U., Kambhampati, S. P., Wu, T., Mishra, M. K., Oh, Y., Sharma, R., Wang, J., Al Towerki, A. E., Yiu, S., Stark, W. J., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.016 · Cited by 170
Mandal, A., Gote, V., Pal, D., Ogundele, A., & Mitra, A. K. (2019) · Pharmaceutical Research · doi:10.1007/s11095-018-2556-5 · Cited by 169
Inflammatory basis for dry eye disease flares
Perez, V. L., Stern, M. E., & Pflugfelder, S. C. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108294 · Cited by 169
Inflammation in Dry Eye Disease
Rhee, M. K., & Mah, F. S. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2017.08.029 · Cited by 166
Davis, B. M., Normando, E. M., Guo, L., Turner, L. A., Nizari, S., O'Shea, P., Moss, S. E., Somavarapu, S., & Cordeiro, M. F. (2014) · Small · doi:10.1002/smll.201303433 · Cited by 164
Han, H., Gao, Y., Chai, M., Zhang, X., Liu, S., Huang, Y., Jin, Q., Grzybowski, A., Ji, J., & Yao, K. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.014 · Cited by 163
Self-citationMartens, T., Remaut, K., Deschout, H. G., Engbersen, J. F. J., Hennink, W. E., van Steenbergen, M. J., Demeester, J., Smedt, S. C. D., & Braeckmans, K. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.030 · Cited by 157
Advances in ocular drug delivery: emphasis on the posterior segment
Kang‐Mieler, J. J., Osswald, C. R., & Mieler, W. F. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.935338 · Cited by 157
Topical cyclosporine A therapy for dry eye syndrome
de Paiva, C. S., Pflugfelder, S. C., Ng, S. M., & Akpek, E. K. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010051.pub2 · Cited by 157
Qian, Y., Deng, S., Cong, Z., Zhang, H., Lu, Z., Shao, N., Bhatti, S. A., Zhou, C., Cheng, J., Gellman, S. H., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c10659 · Cited by 156
Advanced drug delivery and targeting technologies for the ocular diseases
Barar, J., Aghanejad, A., Fathi, M., & Omidi, Y. (2016) · Bioimpacts · doi:10.15171/bi.2016.07 · Cited by 155
Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens
Lakshminarayanan, R., Ye, E., Young, D. J., Li, Z., & Loh, X. J. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701400 · Cited by 155
Bisht, R., Mandal, A., Jaiswal, J. K., & Rupenthal, I. D. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1473 · Cited by 154
Luo, T., Nash, G. T., Xu, Z., Jiang, X., Liu, J., & Lin, W. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c07379 · Cited by 145
Lalu, L., Tambe, V., Pradhan, D., Nayak, K., Bagchi, S., Maheshwari, R., Kalia, K., & Tekade, R. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.035 · Cited by 144
Choonara, Y. E., Pillay, V., Danckwerts, M. P., Carmichael, T. R., & du Toit, L. C. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21987 · Cited by 142
Gan, J., Liu, C., Li, H.-L., Wang, S.-C., Wang, Z.-Z., Kang, Z., Huang, Z., Zhang, J.-F., Wang, C.-M., Lv, D.-L., et al. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119340 · Cited by 142
Cellular strategies for retinal repair by photoreceptor replacement
Jayakody, S. A., Gonzalez-Cordero, A., Ali, R. R., & Pearson, R. A. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.01.003 · Cited by 140
Qiu, F., Meng, T., Chen, Q., Zhou, K., Shao, Y. X., Greg, M. H., Ma, X., Wu, W., Du, Y., Wang, X., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01319 · Cited by 135
Sustained suppression of VEGF for treatment of retinal/choroidal vascular diseases
Campochiaro, P. A., & Akhlaq, A. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100921 · Cited by 132
Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Bressler, N. M., Beck, R. W., & Ferris, F. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmct0908432 · Cited by 131
Zhang, J., & Wang, S. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.001 · Cited by 131
Zhu, K., Qian, S., Guo, H., Wang, Q., Chu, X., Wang, X., Lu, S. T., Peng, Y., Guo, Y., Zhu, Z., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c03971 · Cited by 130
Di Tommaso, C., Bourges, J.-L., Valamanesh, F., Trubitsyn, G., Torriglia, A., Jeanny, J.-C., Behar-Cohen, F., Gurny, R., & Möller, M. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.02.014 · Cited by 128
Strettoi, E., Gargini, C., Novelli, E., Sala, G., Piano, I., Gasco, P., & Ghidoni, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007644107 · Cited by 128
PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab
Elsaid, N., Jackson, T. L., Elsaid, Z., Alqathama, A. A., & Somavarapu, S. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00335 · Cited by 128
Huu, V. A. N., Luo, J., Zhu, J., Zhu, J., Patel, S. H., Boone, A., Mahmoud, E., McFearin, C. L., Olejniczak, J., Lux, C. D. G., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.001 · Cited by 126
Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy
Aiello, P., Consalvi, S., Poce, G., Raguzzini, A., Toti, E., Palmery, M., Biava, M., Bernardi, M., Kamal, M. A., Perry, G. L., et al. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.029 · Cited by 123
Uveitis for the non-ophthalmologist
Burkholder, B. M., & Jabs, D. A. (2021) · BMJ · doi:10.1136/bmj.m4979 · Cited by 123
Role of Metabolism in Ocular Drug Delivery
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335342 · Cited by 122
Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors
Gan, J., Dou, Y., Li, Y., Wang, Z., Wang, L., Liu, S., Li, Q., Yu, H., Liu, C., Han, C., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.06.015 · Cited by 122
Liposomes for effective drug delivery to the ocular posterior chamber
Lai, S., Wei, Y., Wu, Q., Zhou, K., Liu, T., Zhang, Y., Jiang, N., Xiao, W. F., Chen, J., Liu, Q., et al. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0498-7 · Cited by 121
An Update on Ocular Surface Epithelial Stem Cells: Cornea and Conjunctiva
Ramos, T., Scott, D., & Ahmad, S. (2015) · Stem Cells International · doi:10.1155/2015/601731 · Cited by 120
Intravenous treatment of choroidal neovascularization by photo-targeted nanoparticles
Wang, Y., Liu, C., Ji, T., Mehta, M. N., Wang, W., Marino, E. K., Chen, J., & Kohane, D. S. (2019) · Nature Communications · doi:10.1038/s41467-019-08690-4 · Cited by 118
Eldeeb, A. E., Salah, S., & Ghorab, M. M. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1609622 · Cited by 118
Youssef, A. A. A., Dudhipala, N. R., & Majumdar, S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060572 · Cited by 118
Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure
Sheppard, J. D., Comstock, T. L., & Cavet, M. E. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0315-8 · Cited by 117
Protein delivery for retinal diseases: From basic considerations to clinical applications
Sanharawi, M. E., Kowalczuk, L., Touchard, E., Omri, S., de Kozak, Y., & Béhar‐Cohen, F. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.001 · Cited by 116
Lipid-based nano delivery of antimicrobials to control food-borne bacteria
Yousefi, M., Ehsani, A., & Jafari, S. M. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.07.005 · Cited by 116
Management of neovascular age-related macular degeneration
Schmidt-Erfurth, U. M., & Prünte, C. F. (2007) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2007.03.002 · Cited by 115
Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery
Zierden, H. C., Josyula, A., Shapiro, R. L., Hsueh, H. T., Hanes, J. S., & Ensign, L. M. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.12.001 · Cited by 114
Nano-based eye drop: Topical and noninvasive therapy for ocular diseases
Wang, C., & Pang, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114721 · Cited by 114
Ferrostatin‐1‐loaded liposome for treatment of corneal alkali burn via targeting ferroptosis
Wang, K., Jiang, L., Zhong, Y., Zhang, Y., Yin, Q., Su, L., Zhang, X., Han, H., & Yao, K. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10276 · Cited by 113
Self-citationGuo, Z., He, B., Jin, H., Zhang, H., Dai, W., Zhang, L., Zhang, H., Wang, X., Wang, J., Zhang, X., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.031 · Cited by 112
Mu, H., Wang, Y., Chu, Y., Jiang, Y., Hua, H., Chu, L., Wang, K., Wang, A., Liu, W., Li, Y., et al. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474967 · Cited by 112
Alshaikh, R. A., Waeber, C., & Ryan, K. B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114342 · Cited by 111
Luo, L., Lin, T., Yao, C., Kuo, P.-Y., Matsusaki, M., Harroun, S. G., Huang, C.-C., & Lai, J. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.10.041 · Cited by 110
Yandrapu, S. K., Upadhyay, A. K., Petrash, J. M., & Kompella, U. B. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400487f · Cited by 108
Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration
Molday, R. S., Garces, F. A., Scortecci, J. F., & Molday, L. L. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101036 · Cited by 107
Li, M., Xu, Z., Zhang, L., Cui, M., Zhu, M., Guo, Y., Sun, R., Han, J., Song, E., He, Y., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c00680 · Cited by 107
The Blood-Aqueous Barrier in Health and Disease
Coca‐Prados, M. (2014) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000107 · Cited by 106
Almeida, H., Amaral, M. H., Lobão, P., Silva, A. C., & Lobo, J. M. S. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3dp43 · Cited by 105
Khara, J. S., Obuobi, S., Wang, Y., Hamilton, M. S., Robertson, B. D., Newton, S. M., Yang, Y. Y., Langford, P. R., & Ee, P. L. R. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.04.032 · Cited by 105
Recent updates in curcumin delivery
Obeid, M. A., Alsaadi, M., & Aljabali, A. A. A. (2022) · Journal of Liposome Research · doi:10.1080/08982104.2022.2086567 · Cited by 104
Distribution of polymeric nanoparticles in the eye: implications in ocular disease therapy
Swetledge, S., Jung, J. P., Carter, R. T., & Sabliov, C. M. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00745-9 · Cited by 103
Nair, A. B., Shah, J., Al‐Dhubiab, B. E., Jacob, S., Patel, S. S., Venugopala, K. N., Morsy, M. A., Gupta, S., Attimarad, M., Sreeharsha, N., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13040523 · Cited by 103
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain
Korenfeld, M. S., Silverstein, S., Cooke, D. L., Vogel, R., & Crockett, R. S. (2008) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2008.09.024 · Cited by 102
Drug delivery to the posterior segment of the eye for pharmacologic therapy
Shah, S., Denham, L. V., Elison, J. R., Bhattacharjee, P. S., Clément, C., Huq, T. S., & Hill, J. M. (2010) · Expert Review of Ophthalmology · doi:10.1586/eop.09.70 · Cited by 102
Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma
Tabatabaei, S. N., Derbali, R. M., Yang, C., Superstein, R., Hamel, P., Chain, J. L., & Hardy, P. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.014 · Cited by 101
Permana, A. D., Utami, R. N., Layadi, P., Himawan, A., Juniarti, N., Anjani, Q. K., Utomo, E., Mardikasari, S. A., Arjuna, A., & Donnelly, R. F. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120623 · Cited by 100
Wang, J., Tan, J., Luo, J., Huang, P., Zhou, W., Chen, L., Long, L., Zhang, L., Zhu, B., Yang, L., et al. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0251-z · Cited by 99
Khan, N., Zafar, A., Khanna, K., Bhatnagar, A., Ahmad, F. J., & Ali, A. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.04.122 · Cited by 99
Luo, L., Zhang, X., Hirano, Y., Tyagi, P., Barabás, P., Uehara, H., Miya, T. R., Singh, N., Archer, B. J., Qazi, Y., et al. (2013) · ACS Nano · doi:10.1021/nn305958y · Cited by 98
Liu, D., Lian, Y., Fang, Q., Liu, L., Zhang, J., & Li, J. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.113 · Cited by 98
Liu, H.-A., Liu, Y.-L., Ma, Z.-Z., Wang, J.-C., & Zhang, Q. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5891 · Cited by 97
Chandrawati, R., Chang, J. Y. H., Reina‐Torres, E., Jumeaux, C., Sherwood, J. M., Stamer, W. D., Zelikin, A. N., Overby, D. R., & Stevens, M. M. (2017) · Advanced Materials · doi:10.1002/adma.201604932 · Cited by 97
Pan, Q., Xu, Q., Boylan, N. J., Lamb, N. W., Emmert, D. G., Yang, J., Tang, L. J., Heflin, T., Alwadani, S., Eberhart, C. G., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.009 · Cited by 96
Lipid-polyethylene glycol based nano-ocular formulation of ketoconazole
Kakkar, S., Karuppayil, S. M., Raut, J. S., Giansanti, F., Papucci, L., Schiavone, N., & Kaur, I. P. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.08.088 · Cited by 94
Varshochian, R., Jeddi‐Tehrani, M., Mahmoudi, A. R., Khoshayand, M. R., Atyabi, F., Sabzevari, A., Esfahani, M. R., & Dinarvand, R. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.07.014 · Cited by 94
Zhu, Y., Wu, S., Sun, Y., Zou, X., Zheng, L., Duan, S., Wang, J., Yu, B., Sui, R., & Xu, F. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202111066 · Cited by 94
Habot‐Wilner, Z., Noronha, G., & Wykoff, C. C. (2019) · Acta Ophthalmologica · doi:10.1111/aos.14042 · Cited by 93
Emre, E., Yüksel, N., Duruksu, G., Pirhan, D., Subaşı, C., Erman, G., & Karaöz, E. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2014.12.005 · Cited by 91
DNA nanoparticles for ophthalmic drug delivery
de Vries, J. W., Schnichels, S., Hurst, J., Strudel, L., Gruszka, A., Kwak, M., Bartz‐Schmidt, K. U., Spitzer, M. S., & Herrmann, A. P. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.046 · Cited by 91
Lin, S., Ge, C., Wang, D., Xie, Q., Wu, B., Wang, J., Nan, K., Zheng, Q., & Chen, W. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b13851 · Cited by 88
Lennikov, A., Mirabelli, P., Mukwaya, A., Schaupper, M., Thangavelu, M., Lachota, M., Ali, Z., Jensen, L. D., & Lagali, N. (2018) · Angiogenesis · doi:10.1007/s10456-018-9594-9 · Cited by 88
Dukovski, B. J., Juretić, M., Bračko, D., Randjelovic, D. V., Savic, S. D., Crespo-Moral, M., Diebold, Y., Filipović‐Grčić, J., Pepić, I., & Lovrić, J. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118979 · Cited by 88
Liu, Y., Wang, Y., Yang, J., Zhang, H., & Gan, L. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.05.018 · Cited by 86
Huang, D., Chen, Y.-S., Green, C. R., & Rupenthal, I. D. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.034 · Cited by 85
Yu, Y., Chen, D., Li, Y., Yang, W., Tu, J., & Shen, Y. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1458923 · Cited by 85
Zhao, X., Seah, I., Xue, K., Wong, W., Tan, Q. S. W., Ma, X., Lin, Q., Lim, J. Y. C., Liu, Z., Parikh, B. H., et al. (2022) · Advanced Materials · doi:10.1002/adma.202108360 · Cited by 84
Cited by
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
Li, S., Chen, L., & Fu, Y. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01992-2 · Cited by 277
Self-citationAn insight on ophthalmic drug delivery systems: focus on polymeric biomaterials-based carriers
Shafiq, M., Rafique, M., Cui, Y., Pan, L., Do, C.-W., & Ho, E. A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.041 · Cited by 67
Metadata
- Authors
- Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 196
- Pages
- 114770
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W4323350844
- Cited by
- 322
- References
- 385
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.